Lee Rosebush Discusses Compounding Pharmacy Regulations at American Pharmacists Association Annual Meeting

Press Releases / March 10, 2016

Partner Lee Rosebush, PharmD, JD, MBA, spoke during the session, “Compounding Medication: Are You Liable?” at the American Pharmacists Association (APhA) Annual Meeting and Exposition on March 5 in Baltimore. APhA’s conference attracts nearly 10,000 practitioners and academics in pharmacy each year.

Because compounding medication is risky business, pharmacists need to know the potential liability issues at both the state and federal levels. Rosebush discussed the hottest compounding liability topics, including laws affecting intra- and interstate dispensing and distribution, the role of the U.S. Food and Drug Administration versus boards of pharmacy, office versus clinic use, and the legality and ethics of compounding products with questionable proven efficacy and safety, among other topics. Other speakers included Francis Palumbo, PhD, FAPhA, University of Maryland School of Pharmacy, and Tony Park, PharmD, JD, California Pharmacy Lawyers.

Related Services